Insider Trading & Ownership - Kinnate Biopharma Inc. (KNTE)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kinnate Biopharma Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-08
Purchase
2023-05-10
5:49 pm
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
1,780,000$2.8$4,984,00010,192,354
(Indirect)
View
2023-05-08
Purchase
2023-05-10
5:42 pm
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,780,000$2.8$4,984,00010,192,354
(Indirect)
View
2023-05-04
Purchase
2023-05-08
5:22 pm
Kinnate Biopharma Inc.KNTEORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Capital GP VIII LLC
OrbiMed Asia GP IV L.P.
OrbiMed Advisors IV Ltd
OrbiMed Genesis GP LLC
ORBIMED CAPITAL LLC
Director
10% Owner
1,460,932$2.797$4,086,2351,902,937
(Indirect)
View
2023-05-04
Purchase
2023-05-08
5:11 pm
Kinnate Biopharma Inc.KNTEGORDON CARL L
Director
10% Owner
1,460,932$2.797$4,086,2351,902,937
(Indirect)
View
2023-04-28
Purchase
2023-05-02
9:38 pm
Kinnate Biopharma Inc.KNTEGORDON CARL L
Director
10% Owner
1,405,168$2.6146$3,673,9011,328,967
(Indirect)
View
2023-04-28
Purchase
2023-05-02
9:34 pm
Kinnate Biopharma Inc.KNTEORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Capital GP VIII LLC
OrbiMed Asia GP IV L.P.
OrbiMed Advisors IV Ltd
OrbiMed Genesis GP LLC
ORBIMED CAPITAL LLC
Director
10% Owner
1,405,168$2.6146$3,673,9011,328,967
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-01
Tax Withholding
2023-12-05
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
541$2.2568,146
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
1,459$2.2565,593
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
541$2.2528,136
(Direct)
View
2023-09-01
Tax Withholding
2023-09-06
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
1,459$2.3567,052
(Direct)
View
2023-09-01
Tax Withholding
2023-09-06
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
541$2.3528,677
(Direct)
View
2023-09-01
Tax Withholding
2023-09-06
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
541$2.3568,687
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:32 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTESabzevari Helen
Director
25,000$025,000
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:31 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTESmaldone Alsup Laurie
Director
25,000$025,000
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:30 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTEMITCHELL DEAN J
Director
25,000$025,000
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:29 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTEGORDON CARL L
Director
10% Owner
25,000$025,000
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:28 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTEFlaherty Keith T.
Director
25,000$025,000
(Direct)
View
2023-06-12
Option Award
2023-06-13
6:26 pm
N/A
2033-06-12
Kinnate Biopharma Inc.KNTEEpperly Melissa B
Director
25,000$025,000
(Direct)
View
2023-06-01
Tax Withholding
2023-06-05
5:01 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
541$4.369,228
(Direct)
View
2023-06-01
Tax Withholding
2023-06-05
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
541$4.329,218
(Direct)
View
2023-06-01
Tax Withholding
2023-06-05
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
1,459$4.368,511
(Direct)
View
2023-03-01
Tax Withholding
2023-03-03
5:58 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
638$5.2167,295
(Direct)
View
2023-03-01
Tax Withholding
2023-03-03
5:57 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
638$5.2127,286
(Direct)
View
2023-03-01
Tax Withholding
2023-03-03
5:56 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
1,721$5.2167,378
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:54 pm
N/A
2033-03-01
Kinnate Biopharma Inc.KNTEDeSimone Jill
Director
50,000$050,000
(Direct)
View
2023-02-17
Option Award
2023-02-23
2:16 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Capital GP VIII LLC
OrbiMed Asia GP IV L.P.
OrbiMed Advisors IV Ltd
OrbiMed Genesis GP LLC
ORBIMED CAPITAL LLC
Director
10% Owner
550,000$04,593,629
(Indirect)
View

Ownership
2023-02-23
1:58 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEOrbiMed Capital GP VIII LLC
OrbiMed Asia GP IV L.P.
OrbiMed Advisors IV Ltd
Director
10% Owner
0$01,100,000
(Indirect)
View
2023-02-17
Option Award
2023-02-22
4:30 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEGORDON CARL L
Director
10% Owner
550,000$04,593,629
(Indirect)
View
2023-02-17
Other
2023-02-22
2:50 pm
N/A
N/A
Kinnate Biopharma Inc.KNTETananbaum James B.
Director
10% Owner
1,100,000$013,038,311
(Indirect)
View
2023-02-17
Other
2023-02-22
2:49 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,100,000$013,038,311
(Indirect)
View
2023-02-10
Option Award(A)
2023-02-15
11:01 am
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
750,000$0750,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
5:00 pm
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
215,000$0215,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
5:00 pm
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
215,000$0215,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
5:00 pm
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEFarzan Nima
Chief Executive Officer
750,000$0215,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
5:00 pm
N/A
2033-02-10
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
215,000$0215,000
(Direct)
View
2022-12-01
Tax Withholding
2022-12-02
8:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
541$7.7567,933
(Direct)
View
2022-12-01
Tax Withholding
2022-12-02
8:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEKrishnamohan Neha
Chief Financial Officer
1,459$7.7569,099
(Direct)
View
2022-12-01
Tax Withholding
2022-12-02
8:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEMeltz Mark A
COO General Counsel Secretary
541$7.7527,924
(Direct)
View
2022-09-01
Option Award
2022-09-02
5:00 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEWilliams Richard Thomas
Chief Medical Officer
25,000$068,474
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next